We are live on
!
Find out more
BC
Broadwood Capital Portfolio holdings
AUM
$1.42B
1-Year Est. Return
34.72%
This Fund
S&P 500
This Quarter
Est. Return
+11.06%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$497M
AUM Growth
+$28.7M
(+6.1%)
Cap. Flow
-$22.5M
Cap. Flow
% of AUM
-4.53%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$6.49M |
| 2 |
Lineage Cell Therapeutics
LCTX
|
+$1.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$29.6M |
| 2 |
Monster Beverage
MNST
|
+$589K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.17% |
| 2 | Consumer Staples | 21.79% |
Similar funds
PTC
NI
CBA
KC
EWS
IHG
SCM
PPC
Broadwood Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Broadwood Capital held 7 positions worth $497M, up 6.1% from $469M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Broadwood Capital withdrew a net $22.5M in Q4 2013, reducing 2 holdings. Its largest reduction was QUESTCOR PHARMA INC, cutting an estimated $29.6M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Consumer Staples.
Against the trend, Broadwood Capital added an estimated $6.49M to STAAR Surgical.
- Broadwood Capital added most to STAAR Surgical in Q4 2013, an estimated $6.49M increase.
- Broadwood Capital's biggest Q4 2013 reduction was QUESTCOR PHARMA INC, cutting an estimated $29.6M.
- Broadwood Capital's ten largest holdings make up 100% of its $497M portfolio in Q4 2013.
- Broadwood Capital opened 0 new positions and closed 0 in Q4 2013.
- Broadwood Capital's portfolio value rose 6.1% quarter-over-quarter to $497M.
Based on Broadwood Capital's 13F filing for Q4 2013, filed 14 Feb 2014.